Drug Interactions
Comprehensive guide to drug-drug interactions, pharmacokinetic interactions, and interaction management.
Browse the pages below for detailed information.
tasimelteon — MT2 receptor Interaction
Drug-target interaction between tasimelteon and MT2 receptor. Synthetic organic pharmacological agent targeting this protein.
tazarotene — Retinoic acid receptor-α Interaction
Drug-target interaction between tazarotene and Retinoic acid receptor-α. Synthetic organic pharmacological agent targeting this protein.
tazarotene — Retinoic acid receptor-β Interaction
Drug-target interaction between tazarotene and Retinoic acid receptor-β. Synthetic organic pharmacological agent targeting this protein.
tazarotene — Retinoic acid receptor-γ Interaction
Drug-target interaction between tazarotene and Retinoic acid receptor-γ. Synthetic organic pharmacological agent targeting this protein.
tazemetostat — enhancer of zeste 2 polycomb repressive complex 2 subunit Interaction
Drug-target interaction between tazemetostat and enhancer of zeste 2 polycomb repressive complex 2 subunit. Synthetic organic pharmacological agent targeting this protein.
teduglutide — GLP-2 receptor Interaction
Drug-target interaction between teduglutide and GLP-2 receptor. Peptide pharmacological agent targeting this protein.
telisotuzumab vedotin — MET proto-oncogene, receptor tyrosine kinase Interaction
Drug-target interaction between telisotuzumab vedotin and MET proto-oncogene, receptor tyrosine kinase. Antibody pharmacological agent targeting this protein.
telmisartan — AT1 receptor Interaction
Drug-target interaction between telmisartan and AT1 receptor. Synthetic organic pharmacological agent targeting this protein.
temsirolimus — mechanistic target of rapamycin kinase Interaction
Drug-target interaction between temsirolimus and mechanistic target of rapamycin kinase. Synthetic organic pharmacological agent targeting this protein.
teneligliptin — dipeptidyl peptidase 4 Interaction
Drug-target interaction between teneligliptin and dipeptidyl peptidase 4. Synthetic organic pharmacological agent targeting this protein.
tepotinib — MET proto-oncogene, receptor tyrosine kinase Interaction
Drug-target interaction between tepotinib and MET proto-oncogene, receptor tyrosine kinase. Synthetic organic pharmacological agent targeting this protein.
teprotumumab — Insulin-like growth factor I receptor Interaction
Drug-target interaction between teprotumumab and Insulin-like growth factor I receptor. Antibody pharmacological agent targeting this protein.
terazosin — α1A-adrenoceptor Interaction
Drug-target interaction between terazosin and α1A-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
terazosin — α1B-adrenoceptor Interaction
Drug-target interaction between terazosin and α1B-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
terazosin — α1D-adrenoceptor Interaction
Drug-target interaction between terazosin and α1D-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
terbutaline — β2-adrenoceptor Interaction
Drug-target interaction between terbutaline and β2-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
terfenadine — H1 receptor Interaction
Drug-target interaction between terfenadine and H1 receptor. Synthetic organic pharmacological agent targeting this protein.
teriflunomide — dihydroorotate dehydrogenase (quinone) Interaction
Drug-target interaction between teriflunomide and dihydroorotate dehydrogenase (quinone). Synthetic organic pharmacological agent targeting this protein.
teriparatide — PTH1 receptor Interaction
Drug-target interaction between teriparatide and PTH1 receptor. Peptide pharmacological agent targeting this protein.
tesamorelin — GHRH receptor Interaction
Drug-target interaction between tesamorelin and GHRH receptor. Peptide pharmacological agent targeting this protein.
testolactone — CYP19A1 Interaction
Drug-target interaction between testolactone and CYP19A1. Synthetic organic pharmacological agent targeting this protein.
testosterone propionate — Androgen receptor Interaction
Drug-target interaction between testosterone propionate and Androgen receptor. Metabolite pharmacological agent targeting this protein.
tetrabenazine — Vesicular monoamine transporter 2 Interaction
Drug-target interaction between tetrabenazine and Vesicular monoamine transporter 2. Synthetic organic pharmacological agent targeting this protein.
theophylline — A2A receptor Interaction
Drug-target interaction between theophylline and A2A receptor. Natural product pharmacological agent targeting this protein.
theophylline — A2B receptor Interaction
Drug-target interaction between theophylline and A2B receptor. Natural product pharmacological agent targeting this protein.
thioguanine — inosine monophosphate dehydrogenase 1 Interaction
Drug-target interaction between thioguanine and inosine monophosphate dehydrogenase 1. Synthetic organic pharmacological agent targeting this protein.
thioguanine — inosine monophosphate dehydrogenase 2 Interaction
Drug-target interaction between thioguanine and inosine monophosphate dehydrogenase 2. Synthetic organic pharmacological agent targeting this protein.
thioridazine — 5-HT2A receptor Interaction
Drug-target interaction between thioridazine and 5-HT2A receptor. Synthetic organic pharmacological agent targeting this protein.
thioridazine — 5-HT2C receptor Interaction
Drug-target interaction between thioridazine and 5-HT2C receptor. Synthetic organic pharmacological agent targeting this protein.
thiothixene — 5-HT2A receptor Interaction
Drug-target interaction between thiothixene and 5-HT2A receptor. Synthetic organic pharmacological agent targeting this protein.
tiagabine — GAT1 Interaction
Drug-target interaction between tiagabine and GAT1. Synthetic organic pharmacological agent targeting this protein.
ticagrelor — P2Y12 receptor Interaction
Drug-target interaction between ticagrelor and P2Y12 receptor. Synthetic organic pharmacological agent targeting this protein.
timolol — β2-adrenoceptor Interaction
Drug-target interaction between timolol and β2-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
tinzaparin — serpin family C member 1 Interaction
Drug-target interaction between tinzaparin and serpin family C member 1. Synthetic organic pharmacological agent targeting this protein.
tiotropium — M3 receptor Interaction
Drug-target interaction between tiotropium and M3 receptor. Synthetic organic pharmacological agent targeting this protein.
tirabrutinib — Bruton tyrosine kinase Interaction
Drug-target interaction between tirabrutinib and Bruton tyrosine kinase. Synthetic organic pharmacological agent targeting this protein.
tirofiban — integrin αIIbβ3 Interaction
Drug-target interaction between tirofiban and integrin αIIbβ3. Synthetic organic pharmacological agent targeting this protein.
tislelizumab — programmed cell death 1 (CD279) Interaction
Drug-target interaction between tislelizumab and programmed cell death 1 (CD279). Antibody pharmacological agent targeting this protein.
tisotumab vedotin — coagulation factor III, tissue factor Interaction
Drug-target interaction between tisotumab vedotin and coagulation factor III, tissue factor. Antibody pharmacological agent targeting this protein.
tivozanib — fms related receptor tyrosine kinase 1 Interaction
Drug-target interaction between tivozanib and fms related receptor tyrosine kinase 1. Synthetic organic pharmacological agent targeting this protein.
tivozanib — fms related receptor tyrosine kinase 4 Interaction
Drug-target interaction between tivozanib and fms related receptor tyrosine kinase 4. Synthetic organic pharmacological agent targeting this protein.
tivozanib — kinase insert domain receptor Interaction
Drug-target interaction between tivozanib and kinase insert domain receptor. Synthetic organic pharmacological agent targeting this protein.
tocilizumab — Interleukin-6 receptor Interaction
Drug-target interaction between tocilizumab and Interleukin-6 receptor. Antibody pharmacological agent targeting this protein.
tofacitinib — Janus kinase 1 Interaction
Drug-target interaction between tofacitinib and Janus kinase 1. Synthetic organic pharmacological agent targeting this protein.
tofacitinib — Janus kinase 2 Interaction
Drug-target interaction between tofacitinib and Janus kinase 2. Synthetic organic pharmacological agent targeting this protein.
tofacitinib — Janus kinase 3 Interaction
Drug-target interaction between tofacitinib and Janus kinase 3. Synthetic organic pharmacological agent targeting this protein.
tofogliflozin — Sodium/glucose cotransporter 2 Interaction
Drug-target interaction between tofogliflozin and Sodium/glucose cotransporter 2. Synthetic organic pharmacological agent targeting this protein.
tolazoline — α2A-adrenoceptor Interaction
Drug-target interaction between tolazoline and α2A-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
tolazoline — α2B-adrenoceptor Interaction
Drug-target interaction between tolazoline and α2B-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
tolazoline — α2C-adrenoceptor Interaction
Drug-target interaction between tolazoline and α2C-adrenoceptor. Synthetic organic pharmacological agent targeting this protein.
tolbutamide — Kir6.2 Interaction
Drug-target interaction between tolbutamide and Kir6.2. Synthetic organic pharmacological agent targeting this protein.
tolcapone — Catechol-O-methyltransferase Interaction
Drug-target interaction between tolcapone and Catechol-O-methyltransferase. Synthetic organic pharmacological agent targeting this protein.
tolrestat — aldo-keto reductase family 1 member B Interaction
Drug-target interaction between tolrestat and aldo-keto reductase family 1 member B. Synthetic organic pharmacological agent targeting this protein.
tolvaptan — V2 receptor Interaction
Drug-target interaction between tolvaptan and V2 receptor. Synthetic organic pharmacological agent targeting this protein.
tositumomab — CD20 (membrane-spanning 4-domains, subfamily A, member 1) Interaction
Drug-target interaction between tositumomab and CD20 (membrane-spanning 4-domains, subfamily A, member 1). Antibody pharmacological agent targeting this protein.
trametinib — mitogen-activated protein kinase kinase 1 Interaction
Drug-target interaction between trametinib and mitogen-activated protein kinase kinase 1. Synthetic organic pharmacological agent targeting this protein.
trametinib — mitogen-activated protein kinase kinase 2 Interaction
Drug-target interaction between trametinib and mitogen-activated protein kinase kinase 2. Synthetic organic pharmacological agent targeting this protein.
trandolapril — Angiotensin-converting enzyme Interaction
Drug-target interaction between trandolapril and Angiotensin-converting enzyme. Synthetic organic pharmacological agent targeting this protein.
trandolaprilat — Angiotensin-converting enzyme Interaction
Drug-target interaction between trandolaprilat and Angiotensin-converting enzyme. Synthetic organic pharmacological agent targeting this protein.
tranexamic acid — plasminogen Interaction
Drug-target interaction between tranexamic acid and plasminogen. Synthetic organic pharmacological agent targeting this protein.